|
🦁
|
The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity.
8 auth.
A. Girod,
C. Wobus,
Z. Zádori,
M. Ried,
K. Leike,
P. Tijssen,
...
J. Kleinschmidt,
M. Hallek
|
8 |
2002 |
8
🦁
|
|
🦁
|
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
8 auth.
A. Girod,
M. Ried,
C. Wobus,
H. Lahm,
K. Leike,
J. Kleinschmidt,
...
G. Deléage,
M. Hallek
|
8 |
1999 |
8
🦁
|
|
🐬
|
Monoclonal Antibodies against the Adeno-Associated Virus Type 2 (AAV-2) Capsid: Epitope Mapping and Identification of Capsid Domains Involved in AAV-2–Cell Interaction and Neutralization of AAV-2 Infection
C. Wobus,
B. Hügle-Dörr,
A. Girod,
G. Petersen,
M. Hallek,
J. Kleinschmidt
|
8 |
2000 |
8
🐬
|
|
🦁
|
Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
8 auth.
A. Girod,
M. Ried,
C. Wobus,
H. Lahm,
K. Leike,
J. Kleinschmidt,
...
G. Deléage,
M. Hallek
|
7 |
1999 |
7
🦁
|
|
🐜
|
Efficient and selective AAV2-mediated gene transfer directed to human vascular endothelial cells.
10 auth.
S. Nicklin,
H. Buening,
Kate L. Dishart,
M. Alwis,
A. Girod,
Uli Hacker,
...
A. Thrasher,
R. Ali,
M. Hallek,
Andrew H. Baker
|
7 |
2001 |
7
🐜
|
|
🐜
|
In vitro selection of viral vectors with modified tropism: the adeno-associated virus display.
8 auth.
L. Perabò,
H. Büning,
D. Kofler,
M. Ried,
A. Girod,
C. Wendtner,
...
J. Enssle,
M. Hallek
|
7 |
2003 |
7
🐜
|
|
🐜
|
Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies
7 auth.
N. Huttner,
A. Girod,
L. Perabò,
D. Edbauer,
J. Kleinschmidt,
H. Büning,
...
Michael Hallek
|
6 |
2003 |
6
🐜
|
|
🐬
|
Adeno-Associated Virus Capsids Displaying Immunoglobulin-Binding Domains Permit Antibody-Mediated Vector Retargeting to Specific Cell Surface Receptors
M. Ried,
A. Girod,
K. Leike,
H. Büning,
M. Hallek
|
6 |
2002 |
6
🐬
|
|
🦁
|
Erratum: Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2 (Nature Medicine (1999) 5 (1052-1056))
8 auth.
A. Girod,
M. Ried,
C. Wobus,
H. Lahm,
K. Leike,
J. Kleinschmidt,
...
G. Deléage,
M. Hallek
|
6 |
1999 |
6
🦁
|
|
🐬
|
Aptamers as tools for target prioritization and lead identification.
P. Burgstaller,
A. Girod,
M. Blind
|
5 |
2002 |
5
🐬
|
